DAIICHI SANKYO COMPANY LIMITED To Go Ex-Dividend On September 27th, 2024 With 0.264 USD Dividend Per Share

Moomoo NewsJul 9 19:40 ET

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug

BenzingaJun 27 10:13 ET

Merck, Daiichi Lung Cancer Therapy Rejected in U.S.

Seeking AlphaJun 27 07:56 ET

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

BenzingaJun 24 04:51 ET

Reported Earlier, Daiichi Sankyo And AstraZeneca's ENHERTU Shows Progression-Free Survival To 13.2 Months In HR Positive, HER2 Low Metastatic Breast Cancer

BenzingaJun 3 02:49 ET

Why Is AstraZeneca Stock Trading Lower On Tuesday?

BenzingaMay 28 14:32 ET